Results 151 to 160 of about 59,297 (307)
Clinical review 77: evaluation of secondary amenorrhea. [PDF]
, 1996 Michelle P. Warren
openalex +1 more source
Early experience with the gasless vNOTES technique for adnexal surgery
International Journal of Gynecology &Obstetrics, Volume 169, Issue 3, Page 1232-1238, June 2025.Abstract Introduction This study evaluates the feasibility, safety, and outcomes of gasless vNOTES (vaginal Natural Orifice Transluminal Endoscopic Surgery) for benign adnexal surgeries. Materials and Methods This was an observational, retrospective study performed in two centers with over 3 years of experience in vNOTES: the University Hospital Center
Pierre‐Alexis Gauci +5 more
wiley +1 more source
Spontaneous remission in the ahumada : del castillo syndrome [PDF]
, 1970 The association of spontaneous galactorrhea with primary or secondary amenorrhea is a striking clinical picture and has increasingly engaged the attention of clinicians as, during the past two decades, numerous and diverse etiological factors have been ...
Vassallo, Luis A., Xuereb, Dennis
core
Sex chromosome mosaicism in secondary amenorrhea and oligomenorrhea
, 1973 C. J. Dewhurst, Mary Lucas
openalex +1 more source
Thalidomide induces amenorrhea in patients with lupus disease [PDF]
, 1998 José Ordi +5 more
openalex +1 more source
The Journal of Pathology, Volume 266, Issue 2, Page 177-191, June 2025.Abstract Chronic histiocytic intervillositis (CHI) is an inflammatory condition of the placenta, characterised by an abnormal, mainly macrophagic infiltrate within the intervillous space. Recent research suggests that CHI results from a ‘maternal‐foetal rejection’ mechanism, because at least some CHI cases fulfil the criteria for antibody‐mediated ...
Léonie Albersammer +18 more
wiley +1 more source
A Case of Pendred’s Syndrome Presenting with Amenorrhea [PDF]
, 1996 Taonei I. Mushayandebvu +2 more
openalex +1 more source
GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions
Clinical and Translational Science, Volume 18, Issue 6, June 2025.ABSTRACT Glucagon‐like peptide‐1 agonists (GLP‐1A) are increasingly prescribed to treat obesity and type 2 diabetes mellitus in children and adolescents. Emerging evidence suggesting neuropsychiatric effects presents an opportunity for pediatric psychopharmacology but requires careful consideration of potential adverse effects and risk of misuse.
Michael Bartkoski +2 more
wiley +1 more source